Correlation Between Eliem Therapeutics and PDS Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and PDS Biotechnology Corp, you can compare the effects of market volatilities on Eliem Therapeutics and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and PDS Biotechnology.

Diversification Opportunities for Eliem Therapeutics and PDS Biotechnology

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Eliem and PDS is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and PDS Biotechnology go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and PDS Biotechnology

Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.87 times more return on investment than PDS Biotechnology. However, Eliem Therapeutics is 1.15 times less risky than PDS Biotechnology. It trades about -0.29 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.3 per unit of risk. If you would invest  411.00  in Eliem Therapeutics on August 28, 2024 and sell it today you would lose (111.00) from holding Eliem Therapeutics or give up 27.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy90.91%
ValuesDaily Returns

Eliem Therapeutics  vs.  PDS Biotechnology Corp

 Performance 
       Timeline  
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Eliem Therapeutics and PDS Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eliem Therapeutics and PDS Biotechnology

The main advantage of trading using opposite Eliem Therapeutics and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.
The idea behind Eliem Therapeutics and PDS Biotechnology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Managers
Screen money managers from public funds and ETFs managed around the world